(NYSE: TMO) Thermo Fisher Scientific's forecast annual revenue growth rate of 16.29% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 21.21%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 71.81%.
Thermo Fisher Scientific's revenue in 2020 is $28,497,000,000.On average, 7 Wall Street analysts forecast TMO's revenue for 2021 to be $13,108,987,737,042, with the lowest TMO revenue forecast at $12,753,992,138,912, and the highest TMO revenue forecast at $13,519,267,745,000.
In 2022, TMO is forecast to generate $13,054,706,146,342 in revenue, with the lowest revenue forecast at $12,619,301,860,000 and the highest revenue forecast at $13,467,758,049,226.